GE HealthCare Files 8-K Report
Ticker: GEHC · Form: 8-K · Filed: 2024-11-08T00:00:00.000Z
Sentiment: neutral
Topics: sec-filing, 8-k, routine-disclosure
Related Tickers: GEHC
TL;DR
GE HealthCare filed a routine 8-K, no major news.
AI Summary
On November 7, 2024, GE HealthCare Technologies Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or significant events beyond routine reporting were detailed in the provided excerpt.
Why It Matters
This filing indicates GE HealthCare is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing appears to be a standard, routine disclosure without any indication of material adverse events or significant changes.
Key Players & Entities
- GE HealthCare Technologies Inc. (company) — Registrant
- November 7, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41528 (identifier) — Commission File Number
- 88-2515116 (identifier) — IRS Employer Identification No.
- 500 W. Monroe Street, Chicago, IL 60661 (address) — Principal executive offices
- (833) 735-1139 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on "Other Events" and "Financial Statements and Exhibits" as of November 7, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on November 7, 2024.
In which state is GE HealthCare Technologies Inc. incorporated?
GE HealthCare Technologies Inc. is incorporated in Delaware.
What is the principal executive office address for GE HealthCare Technologies Inc.?
The principal executive office address is 500 W. Monroe Street, Chicago, IL 60661.
What is the Commission File Number for GE HealthCare Technologies Inc.?
The Commission File Number for GE HealthCare Technologies Inc. is 001-41528.
From the Filing
0001193125-24-254226.txt : 20241108 0001193125-24-254226.hdr.sgml : 20241108 20241108165931 ACCESSION NUMBER: 0001193125-24-254226 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20241107 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241108 DATE AS OF CHANGE: 20241108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 241441558 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 d803838d8k.htm 8-K 8-K false 0001932393 0001932393 2024-11-07 2024-11-07     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2024     GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)       Delaware   001-41528   88-2515116 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 500 W. Monroe Street , Chicago , IL     60661 (Address of principal executive offices)     (Zip Code) (Registrant’s telephone number, including area code) (833) 735-1139   (Former name or former address, if changed since last report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, par value $0.01 per share   GEHC   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01. Other Events. On November 7, 2024, GE HealthCare Technologies Inc. (the “Company”) announced the commencement and pricing of an underwritten offering (the “Offering”) of 13,281,302 shares of its common stock (the “GEHC Shares”). The Company is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the debt-for-equity exchange (as described below). A copy of the press rele